References
- Standing Medical Advisory Committee and Standing Nursing and Midwifery Advisory Committee. The principles and provision of palliative care. Department of Health, 1993.
- Cella DF, Tulsky DS. Measuring quality of life today: methodological aspects. Oncology 1990; 4: 29–38.
- de Haes JCJ, Knippenberg FCE, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Canncer 1990; 62: 1034–8.
- Zigmond AS, Snaith RR. The Hospital Anxiety and Depression scale. Acta Psychiatr Scand 1983; 67: 361–370.
- Maguire P, Selby P. Assessing the quality of life of cancer patients. Br J Cancer 1989; 60: 437–40.
- Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, European Organization for Research and Treatment of Cancer Study Group on Quality of Life. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–76.
- Cella DF, Tulsky DS, Gray G, Sarajian B, Lloyd S et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11:570–9.
- Muers MF, Round CE. Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation thoracic group. Thorax 1993; 48: 339–43.
- Haynes SE, Ahmedzai S, Morgan MDL. A prospective study of the continuity of care in lung cancer. Thorax 1991; 46: 753 p.
- Medical Research Council Lung Cancer Working Party. Survival, adverse reactions and quality of life during combination chemotherapy compared with selective palliative treatment for small cell lung cancer. Respir Med 1989; 83: 51–8.
- Medical Research Council Lung Cancer Working Party. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC) II: qualityof life. Br J Cancer 1993; 68: 1157–66.
- Medical Research Council Lung Cancer Working Party. Controlled trial of twelve versus six courses of chemotherapy in the treatment of small cell lung cancer. Br J Cancer 1989; 59: 584–90.
- Medical Research Council Lung Cancer Working Party. A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Br J Cancer 1992; 65: 934–41.
- Dand P, Field D, Ahmedzai S, Biswas B. Client satisfaction with care at the Leicestershire Hospice. Trent Palliative Care Centre Occasional Paper No. 2.